Androgens 2016              Start: Thursday Sept. 15, 2. pm – End: Saturday Sept. 17, 3:30 pm

Invited Speakers

  • Jean-Mark Kaufman, Ghent, B – Determinants and clinical correlates of androgen exposure: phases of life and disease
  • Christopher Wright, Baltimore, US – Neuro-inflammatory origins of the sexual differentiation of the brain
  • Jorma Palvimo, Kuopio, FI – Modulation of androgen receptor signaling in prostate cancer cells by SUMOylation and NFkappaB pathways
  • Scott Dehm, Minneapolis, US – Androgen receptor: master contortionist in prostate cancer
  • Matti Poutanen, Turku, FI – Regulating androgen action by steroid synthesis and metabolism
  • Charles Massie, Cambridge, UK – Causes and consequences of metabolic changes in prostate tumours
  • Mario Maggi, Florence, IT – Androgens and cardiovascular diseases
  • Farid Saad, Berlin, D – Effects of long-term testosterone therapy on obesity, glycaemic control and other features of the metabolic syndrome
  • Wilbert Zwart, Amsterdam, NL – The androgenreceptor chromatin landscape in prostate tumors: biomarker discovery and beyond
  • Eva Estebanez-Perpina, Barcelona, E – Three-dimensional structure of homodimeric androgen receptor ligand-binding domain
  • Gero Kramer, Vienna, A – Treatment of castration-resistant prostate cancer
  • Felix Y Feng, Ann Arbor, US – Identifying drivers of disease progression to personalize prostate cancer therapy
  • Francesca Demichelis, Trento, IT – The genetics of prostate cancer specific events
  • Holger Sültmann, Heidelberg, D – Genomic and epigenomic patterns in prostate cancer

Download final Program                                         Download final Programm&Abstracts